Phase I pharmacokinetic trial of arbaclofen placarbil in volunteers: exposure levels compared with exposure levels achieved with highest approved dosage of racemic baclofen.
Phase of Trial: Phase I
Latest Information Update: 20 May 2013
At a glance
- Drugs Arbaclofen placarbil (Primary) ; Baclofen
- Indications Multiple sclerosis; Muscle spasticity
- Focus Pharmacokinetics
- 17 Feb 2012 Status changed from planning to recruiting.
- 26 Apr 2011 New trial record